In this discussion, we will review currently available tests for detecting alpha synuclein in conditions related to Parkinson’s disease. We will also review new areas of research for both detection and therapeutic targeting of alpha synuclein.
Thank you to CND Life Sciences for partnering with PMD Alliance on this program.
Parkinson & Movement Disorder Alliance is a nonprofit organization providing people with Parkinson's and other movement disorders as well as their care partners opportunities to learn, live life more fully and connect with other. We believe you are MORE than a disease!